Catherine Gleeson

A judge has ordered the administrator for two class actions over PFAS contamination that settled for $153 million to pay the leftover funds to group members rather than to charities, saying it was not appropriate “to go around making donations”. 

A community group has lost a legal challenge to a 50-60 km underground pipeline that will connect Santos’ $3.6 billion Narrabri gas project to the Hunter gas pipeline. 

A judge has approved a "modest" $8.7 million settlement in a class action against medical device maker Exactech over allegedly defective joint replacements, saying the settlement was fair and reasonable given the limited assets of the company, whose parent has filed for bankruptcy in the US.

Private equity firm Goldstone has lost its bid to disqualify a judge from a damages hearing after he found it liable for shareholder oppression of its managing director.

Testing lab ALS Limited has partially lost its bid to shield a forensic investigation by McGrathNicol in relation to claims of exaggerated coal testing results, with a judge finding it sought to use the findings to dissuade regulators and others from bringing claims.

Private equity firm Goldstone has lost its bid to lodge an appeal before damages are determined, after a judge found  it invalidly terminated its managing director’s employment for standing in the way of a deal with her business partner’s son.

Private equity firm Goldstone has cited an "irretrievable breakdown" in the relationship between shareholders in seeking to appeal a ruling that found it liable for oppression.

A private equity fund is challenging a ruling that it acted in an “oppressive” and “unfairly prejudicial” way towards its managing director, who a judge found was invalidly sacked for standing in the way of a deal with her business partner’s son. 

Medical device maker Exactech will pay $8.7 million to end a class action that alleges its joint replacement implants were defective. 

Medical device maker Exactech has reached a settlement in a class action over alleged defective implants, following the US company's bankruptcy.